Economic impact of Acinetobacter baumannii infection in the intensive care unit.
作者信息
Lee Bruce Y, McGlone Sarah M, Doi Yohei, Bailey Rachel R, Harrison Lee H
机构信息
Public Health Computational and Operations Research, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, USA.
出版信息
Infect Control Hosp Epidemiol. 2010 Oct;31(10):1087-9. doi: 10.1086/656378.
Abstract
摘要
相似文献
1
Economic impact of Acinetobacter baumannii infection in the intensive care unit.重症监护病房中鲍曼不动杆菌感染的经济影响。
Infect Control Hosp Epidemiol. 2010 Oct;31(10):1087-9. doi: 10.1086/656378.
2
Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit.外科重症监护病房中克隆性多重耐药鲍曼不动杆菌感染暴发的流行病学、临床及经济学评估
Infect Control Hosp Epidemiol. 2007 Nov;28(11):1247-54. doi: 10.1086/521660. Epub 2007 Sep 6.
3
Economic value of Acinetobacter baumannii screening in the intensive care unit.鲍曼不动杆菌筛查在重症监护病房的经济价值。
Clin Microbiol Infect. 2011 Nov;17(11):1691-7. doi: 10.1111/j.1469-0691.2011.03491.x. Epub 2011 Apr 4.
4
Carbapenemase-producing Acinetobacter baumannii: An outbreak report with special highlights on economic burden.产碳青霉烯酶鲍曼不动杆菌：一份爆发报告，特别强调经济负担
Med Mal Infect. 2017 Jun;47(4):279-285. doi: 10.1016/j.medmal.2017.02.006. Epub 2017 Mar 23.
5
Factors associated with recovery of Acinetobacter baumannii in a combat support hospital.与鲍曼不动杆菌在战斗支援医院中的恢复相关的因素
Infect Control Hosp Epidemiol. 2008 Jul;29(7):664-6. doi: 10.1086/589585.
6
Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia.哥伦比亚鲍曼不动杆菌感染患者的碳青霉烯类耐药对临床和经济结局的影响。
Clin Microbiol Infect. 2014 Feb;20(2):174-80. doi: 10.1111/1469-0691.12251. Epub 2013 May 13.
7
Cost-analysis of an intensive care unit closure due to an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak.
J Hosp Infect. 2011 Feb;77(2):174-5. doi: 10.1016/j.jhin.2010.09.027. Epub 2010 Dec 30.
8
Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.鲍曼不动杆菌中碳青霉烯类耐药的流行病学和影响。
Infect Control Hosp Epidemiol. 2009 Dec;30(12):1186-92. doi: 10.1086/648450.
9
Molecular epidemiology of Acinetobacter baumannii in central intensive care unit in Kosova Teaching Hospital.科索沃教学医院中心重症监护病房鲍曼不动杆菌的分子流行病学研究。
Braz J Infect Dis. 2009 Dec;13(6):408-13. doi: 10.1590/s1413-86702009000600004.
10
Nosocomial Acinetobacter baumannii infection in children in adult versus pediatric intensive care units.成人与儿科重症监护病房儿童中鲍曼不动杆菌医院感染。
Pediatr Int. 2020 Apr;62(4):451-458. doi: 10.1111/ped.14133. Epub 2020 Apr 6.
引用本文的文献
1
The intricacies of : a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications.……的复杂性：对一种多重耐药病原体及其临床意义和影响的多方面综合综述。 （注：原文开头部分不完整，翻译出来的句子也有部分成分缺失，不太能构成完整通顺的表述）
Front Microbiol. 2025 May 12;16:1565965. doi: 10.3389/fmicb.2025.1565965. eCollection 2025.
2
The burden of carbapenem-resistant infection in a large Thai tertiary care hospital.泰国一家大型三级护理医院中耐碳青霉烯类感染的负担。
Front Pharmacol. 2022 Sep 2;13:972900. doi: 10.3389/fphar.2022.972900. eCollection 2022.
3
The Economic Impact of Carbapenem Resistant-Non Lactose Fermenter and Infections on Hospital Costs in Dr. Soetomo General Academic Hospital Surabaya, Indonesia.耐碳青霉烯类非乳糖发酵菌感染对印度尼西亚泗水苏托莫综合学术医院医院成本的经济影响。
Antibiotics (Basel). 2022 May 20;11(5):694. doi: 10.3390/antibiotics11050694.
4
Facing the challenges of multidrug-resistant : progress and prospects in the vaccine development.面对多药耐药性的挑战：疫苗开发的进展与前景。
Hum Vaccin Immunother. 2021 Oct 3;17(10):3784-3794. doi: 10.1080/21645515.2021.1927412. Epub 2021 Jun 9.
5
The effect of temporary closure and enhanced terminal disinfection using aerosolized hydrogen peroxide of an open-bay intensive care unit on the acquisition of extensively drug-resistant Acinetobacter baumannii.开放式重症监护病房使用过氧化氢雾化进行临时关闭和强化终末消毒对获得广泛耐药鲍曼不动杆菌的影响。
Antimicrob Resist Infect Control. 2020 Jul 14;9(1):108. doi: 10.1186/s13756-020-00772-z.
6
Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.美国耐碳青霉烯类肠杆菌科细菌（CRE）的潜在经济负担。
Clin Microbiol Infect. 2017 Jan;23(1):48.e9-48.e16. doi: 10.1016/j.cmi.2016.09.003. Epub 2016 Sep 15.
7
Clinical and economic outcomes of Acinetobacter vis a vis non-Acinetobacter infections in an Indian teaching hospital.印度一家教学医院中不动杆菌感染与非不动杆菌感染的临床和经济结果对比
Perspect Clin Res. 2016 Jan-Mar;7(1):28-31. doi: 10.4103/2229-3485.173778.
8
Modeling the impact of interventions against Acinetobacter baumannii transmission in intensive care units.模拟重症监护病房中针对鲍曼不动杆菌传播的干预措施的影响。
Virulence. 2016;7(2):141-52. doi: 10.1080/21505594.2015.1076615. Epub 2015 Aug 7.
9
Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex.鲍曼不动杆菌-醋酸钙不动杆菌复合体所致血流感染患者的危险因素及预后
Antimicrob Agents Chemother. 2014 Aug;58(8):4630-5. doi: 10.1128/AAC.02441-14. Epub 2014 Jun 2.
10
Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway.多黏菌素快速杀灭鲍曼不动杆菌是通过羟基自由基死亡途径介导的。
Antimicrob Agents Chemother. 2012 Nov;56(11):5642-9. doi: 10.1128/AAC.00756-12. Epub 2012 Aug 20.
本文引用的文献
1
Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.通过综合“捆绑”方法实现医院范围内地方性多重耐药鲍曼不动杆菌的长期控制。
Am J Infect Control. 2009 Nov;37(9):715-22. doi: 10.1016/j.ajic.2009.01.008. Epub 2009 May 19.
2
Cost-effectiveness of implementing low-tidal volume ventilation in patients with acute lung injury.对急性肺损伤患者实施低潮气量通气的成本效益分析。
Chest. 2009 Jul;136(1):79-88. doi: 10.1378/chest.08-2123. Epub 2009 Mar 24.
3
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.国家医疗安全网络年度更新：与医疗保健相关感染有关的抗菌药物耐药病原体：2006 - 2007年向疾病控制和预防中心国家医疗安全网络报告的数据年度总结
Infect Control Hosp Epidemiol. 2008 Nov;29(11):996-1011. doi: 10.1086/591861.
4
Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes.多重耐药鲍曼不动杆菌对临床结局的影响。
Eur J Clin Microbiol Infect Dis. 2007 Nov;26(11):793-800. doi: 10.1007/s10096-007-0371-8.
5
Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.医院获得性鲍曼不动杆菌血流感染中多重耐药的临床和经济影响
Infect Control Hosp Epidemiol. 2007 Jun;28(6):713-9. doi: 10.1086/517954. Epub 2007 May 14.
6
Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.多重耐药鲍曼不动杆菌感染的死亡率和住院时间。
Emerg Infect Dis. 2007 Jan;13(1):97-103. doi: 10.3201/eid1301.060716.
7
Attributable mortality of nosocomial Acinetobacter bacteremia.医院获得性不动杆菌菌血症的归因死亡率。
Infect Control Hosp Epidemiol. 2007 Mar;28(3):293-8. doi: 10.1086/512629. Epub 2007 Feb 7.
8
The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudmonas aeruginosa on length of hospital stay.抗生素耐药性的代价：金黄色葡萄球菌、肺炎克雷伯菌、鲍曼不动杆菌和铜绿假单胞菌的耐药性对住院时间的影响。
Infect Control Hosp Epidemiol. 2002 Feb;23(2):106-8. doi: 10.1086/502018.
9
Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital.城市教学医院中鲍曼不动杆菌感染与定植及抗菌治疗模式的评估
Pharmacotherapy. 1999 Sep;19(9):1080-5. doi: 10.1592/phco.19.13.1080.31597.
10
Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients.重症患者因感染不动杆菌导致的死亡率及住院时间延长情况。
Crit Care Med. 1999 Sep;27(9):1794-9. doi: 10.1097/00003246-199909000-00015.
Zotero 插件